Module

AIDS-related Lymphoma: Update 2005

Source: Lymphoma Annual Update 2005

AIDS-related Lymphoma: Update 2005


Program Director: Julie M. Vose, MD

Faculty:

  • Alexandra M. Levine, MD

CME CREDIT INFORMATION

Release Date: 09/14/05

Expiration Date: 09/13/06


Physicians: maximum of 1 AMA PRA Category 1 Credit(s)™

Registered Nurses: 1.5 Nursing CE credits

Status: Please log in to view status


Learning Objectives

Upon completion of this activity, participants should be able to:

  • Review histopathology, staging, and prognostic indicators for AIDS-related lymphoma.

  • Evaluate state-of-the-art treatment options for AIDS-related lymphoma.

  • Discuss HAART’s impact on the decreasing incidence and improved survival of AIDS-related lymphoma.

  • Describe the incidence, pathogenesis, and treatment of HIV-related Hodgkin’s disease.


Content includes:

  • Impact of HAART on AIDS-related Lymphoma
  • Etiology and Pathogenesis of AIDs-related Lymphoma
  • Histopathology and Staging of ARLs
  • Standard vs Low-Dose Chemotherapy for ARL
  • Optimal Timing of HAART and Chemotherapy
  • Rituximab in ARL
  • Role of CNS Prophylaxis
  • Management of Relapsed or Refractory AIDS-Related Lymphoma
  • Hodgkin's Disease in Patients with HIV
Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.

Jointly sponsored by Postgraduate Institute for Medicine and Clinical Care Options, LLC.

Educational grants provided by:

Educational grants support only the CME-certified components of this program.